𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes

✍ Scribed by G. Derosa; A. F. G. Cicero; A. D’Angelo; E. Fogari; P. Maffioli

Book ID
114738624
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
620 KB
Volume
37
Category
Article
ISSN
0269-4727

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pravastatin compared to bezafibrate in t
Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus
✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Effect of insulin on renal sodium handli
Effect of insulin on renal sodium handling in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance
✍ P. Skøtt; A. Vaag; N. E. Bruun; O. Hother-Nielsen; M.-A. Gall; H. Beck-Nielsen; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 839 KB

The sodium retaining effect of insulin was studied in ten Type 2 (non-insulin-dependent) diabetic patients (mean age 56 (43-73)years, mean body mass index 29.5 (24.2-33.7) kg/m o and eight age-matched control subjects (mean age 57 (43~58)years, mean body mass index 23.4 (20.8-26.6) kg/m2). The renal